Regenerative Medicine and Orthobiologics

Advanced, Minimally Invasive Treatments for Sports Injuries, Joint Pain, and Orthopedic Conditions

Traditional orthopedic treatment often focuses on controlling pain, reducing inflammation, or surgically repairing damaged tissue. These approaches remain important and may be necessary for certain injuries. However, they do not always address the biological environment responsible for tissue healing.

Regenerative medicine offers another approach.

In sports medicine and orthopedics, regenerative medicine uses biologically active treatments—often called orthobiologics—to support the body’s natural repair processes. These treatments are designed to improve the environment surrounding an injured joint, tendon, ligament, muscle, or other musculoskeletal structure.

Rather than simply masking symptoms, regenerative medicine treatments may help:

• Stimulate tissue-repair signaling

• Improve the local healing response

• Support collagen production and remodeling

• Regulate excessive or prolonged inflammation

• Improve joint function

• Reduce pain

• Support recovery from chronic or acute injuries

• Delay or potentially avoid more invasive procedures in appropriately selected patients

Platelet-rich plasma, or PRP, is one of the most established and commonly used regenerative medicine treatments in orthopedic and sports medicine practice.

What Is Regenerative Medicine?

Regenerative medicine is a broad area of healthcare focused on repairing, restoring, or supporting damaged cells and tissues.

Within orthopedic and sports medicine, regenerative medicine generally refers to treatments that use biological substances to influence healing. Many of these substances are collected from the patient’s own blood or bone marrow, processed to concentrate specific biological components, and then delivered directly to the injured area.

These treatments are frequently described as orthobiologics.

The term orthobiologic refers to a biological product used to support the treatment of an orthopedic or musculoskeletal condition. Orthobiologics may contain platelets, growth factors, signaling proteins, anti-inflammatory proteins, cells, or other biologically active components.

Common orthopedic regenerative medicine treatments include:

• Platelet-rich plasma

• Platelet concentrates

• Plasma-based prolotherapy

• Bone marrow aspirate concentrate

• Autologous conditioned serum

• Growth factor concentrates

• Certain cellular or tissue-derived products

• Emerging extracellular vesicle and exosome technologies

The composition, regulatory status, supporting evidence, and appropriate use differ significantly between these treatment categories. Regenerative medicine is not a single treatment, and not every product marketed as regenerative medicine has the same level of evidence or regulatory status.

How Regenerative Medicine Works

When a tissue is injured, the body initiates a coordinated repair response.

Platelets, immune cells, growth factors, blood vessels, connective-tissue cells, and extracellular signaling molecules work together to stabilize the injury and begin rebuilding the damaged area.

However, the healing response may become limited or incomplete when:

• The tissue has poor blood flow

• The injury is repeatedly overloaded

• The damage has been present for an extended period

• The joint environment remains chronically inflamed

• The tissue has undergone degenerative changes

• Normal collagen organization has been disrupted

• The patient has metabolic or nutritional factors that impair recovery

• Rehabilitation does not provide the correct mechanical stimulus

Regenerative medicine treatments attempt to improve this biological environment.

Depending on the treatment, this may involve concentrating the patient’s own platelets, increasing the delivery of growth factors, modifying inflammatory signaling, recruiting repair-related cells, or providing a scaffold that supports tissue remodeling.

These treatments do not create an entirely new joint, tendon, or ligament. They are intended to support the body’s existing capacity for repair and improve the conditions under which healing occurs.

What Conditions Can Regenerative Medicine Treat?

Orthopedic regenerative medicine may be considered for a range of acute injuries, chronic overuse conditions, and degenerative joint problems.

Potential treatment areas include:

Tendon Injuries

• Rotator cuff tendinopathy

• Partial rotator cuff tears

• Tennis elbow

• Golfer’s elbow

• Patellar tendinopathy

• Achilles tendinopathy

• Gluteal tendinopathy

• Proximal hamstring tendinopathy

• Biceps or triceps tendon injuries

• Plantar fascia injuries

Ligament Injuries

• Partial ligament tears

• Chronic ligament sprains

• Ankle instability

• Medial collateral ligament injuries

• Selected partial knee ligament injuries

• Joint instability related to ligament laxity

Joint and Cartilage Conditions

• Knee osteoarthritis

• Hip osteoarthritis

• Shoulder arthritis

• Ankle arthritis

• Cartilage defects

• Meniscal injuries

• Labral injuries

• Joint inflammation

• Early degenerative joint disease

Muscle and Fascial Injuries

• Muscle strains

• Chronic muscular injuries

• Myotendinous injuries

• Scar tissue

• Fascial pain

• Persistent sports-related soft-tissue injuries

Recovery After Surgery

Regenerative medicine may also be incorporated into selected surgical recovery plans to support healing, tissue integration, and rehabilitation.

The appropriate treatment depends on the diagnosis, tissue involved, severity of the damage, patient health, functional goals, and available evidence.

Platelet-Rich Plasma: A Leading Regenerative Medicine Treatment

What Is PRP?

Platelet-rich plasma, commonly called PRP, is an autologous regenerative medicine treatment prepared from the patient’s own blood.

A blood sample is collected and processed in a centrifuge to separate and concentrate the platelets and plasma. The resulting platelet concentrate is then injected into the injured tissue or joint, typically using musculoskeletal ultrasound guidance.

Platelets are widely known for their role in blood clotting, but they also contain biologically active proteins involved in tissue repair.

When platelets become activated, they release growth factors and signaling molecules that influence:

• Collagen production

• Cellular recruitment

• Blood-vessel formation

• Inflammatory regulation

• Tissue remodeling

• Extracellular matrix production

• Tendon and ligament healing

• Joint homeostasis

PRP does not contain a medication or corticosteroid. It uses concentrated components of the patient’s own blood to stimulate a localized healing response.

Why Platelet Concentration Matters

Not every PRP treatment is the same.

PRP quality can vary significantly depending on:

• The amount of blood collected

• The centrifuge system

• The processing method

• Platelet recovery

• Final injection volume

• Platelet concentration

• Total platelet dose

• White blood cell concentration

• Red blood cell contamination

• Whether the product is activated

• The tissue being treated

• The accuracy of injection placement

The term “PRP” alone does not describe the final biological dose.

A small-volume blood draw processed through a basic system may produce a substantially different treatment than a high-volume, laboratory-style preparation designed to deliver a larger number of concentrated platelets.

Research increasingly suggests that the total platelet dose may influence clinical outcomes in conditions such as knee osteoarthritis. However, the optimal preparation is not identical for every injury, and treatment should be selected according to the diagnosis and tissue biology.

How PRP May Help Injured Tissue

PRP is intended to stimulate and organize a new healing response in tissue that may have become chronically irritated, degenerative, or biologically inactive.

Potential effects include:

Growth Factor Release

Activated platelets release signaling proteins that participate in tissue repair and cellular communication.

Collagen Production

PRP may stimulate fibroblast and tenocyte activity, helping support collagen synthesis and remodeling in tendons and ligaments.

Inflammatory Regulation

PRP does not simply eliminate inflammation. Instead, it may help shift the tissue away from prolonged, dysfunctional inflammation and toward a more organized repair process.

Vascular Signaling

Certain platelet-derived factors may support the formation of new microvascular networks within healing tissue.

Joint Environment Support

When injected into a joint, PRP may help regulate inflammatory signaling and improve symptoms related to osteoarthritis.

Tissue Remodeling

PRP may support the gradual replacement and reorganization of damaged extracellular tissue.

These biological effects take time. PRP is not an immediate numbing injection, and improvement often develops over several weeks to months.

Conditions Commonly Treated With PRP

PRP is used across sports medicine and orthopedic practice, but the amount and quality of evidence vary by condition.

Knee Osteoarthritis

PRP may reduce pain and improve function in patients with symptomatic knee osteoarthritis. The American Academy of Orthopaedic Surgeons states that PRP may provide improvement, although the strength of the recommendation remains limited because treatment preparation and study protocols vary.

Recent comparative research has also found that PRP can improve pain and function compared with placebo and may perform favorably compared with several other injectable treatments.

PRP does not reverse advanced arthritis or guarantee that joint replacement will be avoided. It may help improve symptoms, joint function, and activity tolerance in appropriately selected patients.

Lateral Epicondylitis

Lateral epicondylitis, commonly known as tennis elbow, is one of the more established orthopedic indications for PRP.

The condition is generally related to chronic degeneration of the common extensor tendon rather than simple short-term inflammation. PRP may help stimulate tendon remodeling and improve long-term pain and function.

Clinical reviews have found supportive evidence for leukocyte-rich PRP in chronic lateral epicondylitis.

Patellar Tendinopathy

PRP may be considered for chronic patellar tendon pain that has not responded adequately to progressive loading, physical therapy, and activity modification.

Treatment should still be combined with a structured tendon-loading program.

Plantar Fasciitis

PRP may be used for chronic plantar fasciitis or plantar fasciopathy when symptoms persist despite conservative treatment.

The goal is to stimulate remodeling at the damaged plantar fascia rather than temporarily suppressing symptoms.

Rotator Cuff and Shoulder Conditions

PRP may be considered for selected rotator cuff tendon injuries, partial tears, and chronic tendinopathy.

Evidence is mixed and depends on the specific diagnosis, tear severity, PRP preparation, and whether treatment is performed as a stand-alone injection or during surgery. PRP should not be presented as a universal replacement for surgical repair when a significant or complete tendon tear is present.

Achilles Tendinopathy

PRP is sometimes used for chronic Achilles tendon disease, particularly after an appropriate eccentric or progressive loading program has failed.

Clinical results are variable, and an accurate diagnosis is essential because insertional tendinopathy, midportion tendinopathy, partial tearing, and paratenon disorders may require different treatment strategies.

Ligament, Meniscus, and Labral Injuries

PRP may be considered for selected partial ligament injuries, meniscal pathology, and labral injuries.

The AAOS notes that PRP can be considered as an adjunct during surgical repair of certain acute isolated meniscal tears.

For nonsurgical cases, results depend greatly on the location, blood supply, stability, mechanical demands, and severity of the injury.

Bone Marrow Aspirate Concentrate

Bone marrow aspirate concentrate, or BMAC, is prepared by collecting bone marrow—commonly from the pelvis—and concentrating its cellular and signaling components.

BMAC may contain:

• Platelets

• White blood cells

• Growth factors

• Cytokines

• Hematopoietic cells

• A relatively small number of mesenchymal stromal cells

• Other marrow-derived signaling components

BMAC is sometimes casually described as a “stem cell injection.” However, this wording can be misleading.

Bone marrow aspirate concentrate is a mixed biological product. It contains many components, and the number of mesenchymal stromal cells present is relatively limited. Its potential effects are thought to involve signaling, inflammatory regulation, cellular communication, and support of the local tissue environment—not simply the growth of entirely new cartilage.

Systematic reviews suggest that BMAC may improve pain and function in patients with knee osteoarthritis. However, current evidence has not consistently demonstrated that BMAC is clinically superior to PRP or other injection treatments, and additional research is needed.

BMAC may be considered for selected patients based on the degree of degeneration, previous treatments, biological goals, and provider assessment.

Autologous Conditioned Serum and Growth Factor Concentrates

Autologous conditioned serum, sometimes referred to as ACS, is another blood-derived regenerative medicine treatment.

Unlike PRP, which focuses primarily on concentrating platelets, ACS preparation is intended to increase specific anti-inflammatory proteins and signaling molecules.

One of the most discussed components is interleukin-1 receptor antagonist, or IL-1Ra. This protein may help block some of the inflammatory signaling associated with osteoarthritis and chronic joint irritation.

Growth factor and conditioned-serum treatments may be considered for:

• Osteoarthritis

• Chronic joint inflammation

• Selected tendon disorders

• Patients who have not responded to conventional injection treatments

• Situations where inflammatory regulation is a major treatment goal

Preparation methods vary, and these treatments should not be assumed to be biologically identical.

A2M and Other Anti-Inflammatory Orthobiologics

Alpha-2-macroglobulin, commonly called A2M, is a naturally occurring protein found in blood plasma.

A2M acts as a broad protease inhibitor. Proteases are enzymes that can contribute to cartilage and tissue breakdown when excessively active within an inflamed or degenerative joint.

Concentrated A2M-based treatments are intended to:

• Bind selected cartilage-degrading enzymes

• Support a healthier joint environment

• Reduce destructive inflammatory activity

• Complement platelet-derived repair signaling

• Protect remaining cartilage and connective tissue

A2M is sometimes combined with PRP to provide both anabolic signaling from platelets and additional regulation of catabolic enzymes within a degenerative joint.

Evidence and protocols continue to evolve. Treatment should be explained as a biologically based option rather than a guaranteed method of regrowing cartilage.

Extracellular Vesicles and Exosomes

Extracellular vesicles are microscopic particles released by cells. They carry proteins, lipids, messenger RNA, microRNA, and other biological signals between cells.

Exosomes are one type of extracellular vesicle.

These products are being studied for their potential ability to:

• Influence immune signaling

• Regulate inflammation

• Support cell-to-cell communication

• Promote cartilage and connective-tissue research pathways

• Support recovery within damaged tissue environments

However, exosome therapy remains an emerging and investigational area.

There are currently no FDA-approved exosome products for orthopedic conditions. Products marketed as exosomes can differ substantially in their source, processing, purity, concentration, sterility, and biological contents.

Patients considering extracellular vesicle or exosome products should receive clear information about their regulatory status, supporting evidence, sourcing, and potential risks.

Why Regenerative Medicine Is Growing in Sports Medicine

Regenerative medicine has become increasingly incorporated into sports medicine because it offers a treatment approach that can be coordinated with the biology and mechanics of healing.

Minimally Invasive Treatment

Many orthobiologic procedures are performed through an injection rather than an incision.

This may reduce the recovery burden associated with surgery and allow the treatment to be performed in an outpatient setting.

Uses the Patient’s Own Biology

PRP, plasma concentrates, conditioned serum, and BMAC are collected from the patient’s own body.

This reduces the risk of allergic reaction to the injected biological material, although procedural risks such as infection, bleeding, pain, and treatment failure remain possible.

Reduced Dependence on Symptom-Suppressing Medication

Corticosteroids, NSAIDs, and pain medications may be appropriate in certain circumstances. However, repeated or prolonged use can have limitations.

Regenerative medicine provides a different strategy—one focused on improving the tissue environment rather than repeatedly suppressing symptoms.

Can Be Combined With Rehabilitation

Regenerative medicine does not replace physical therapy or progressive strengthening.

The best outcomes often occur when biological treatment is paired with:

• Progressive mechanical loading

• Physical therapy

• Mobility restoration

• Biomechanical correction

• Nutrition

• Adequate protein intake

• Sleep and recovery

• Gradual return to activity

May Delay More Invasive Treatment

In appropriately selected patients, regenerative medicine may help improve pain and function enough to delay surgery or joint replacement.

It cannot guarantee that surgery will never be required. Complete tendon ruptures, unstable ligament injuries, advanced mechanical joint damage, severe fractures, and other structural conditions may still require surgical evaluation.

Regenerative Medicine Is Not a Shortcut

Regenerative medicine should not be viewed as a single injection that instantly heals an injury.

Tissue recovery depends on:

• The correct diagnosis

• The severity and duration of the injury

• The patient’s age and overall health

• Blood flow to the injured structure

• Metabolic health

• Nutrition

• Sleep

• Tobacco use

• Hormonal status

• Medication use

• Rehabilitation compliance

• Activity modification

• The accuracy and quality of the procedure

A biologic treatment can provide a powerful signal, but the tissue still requires adequate time, nutrition, and mechanical loading to remodel.

The Importance of Diagnostic Imaging

A successful regenerative medicine procedure begins with identifying the correct pain generator.

Pain in the shoulder, hip, knee, or back may come from several different structures. Treating the location of pain without identifying the damaged tissue can lead to poor outcomes.

Musculoskeletal ultrasound and MRI may be used to evaluate:

• Tendon tears

• Tendon degeneration

• Ligament injuries

• Cartilage damage

• Joint inflammation

• Bursitis

• Meniscal or labral pathology

• Calcification

• Scar tissue

• Muscle injuries

• Joint instability

Diagnostic ultrasound can also be used during the procedure to visualize the needle and confirm that the orthobiologic product is delivered directly to the intended structure.

Why Ultrasound Guidance Matters

Regenerative medicine injections should be performed with precision.

Musculoskeletal ultrasound allows the provider to observe the needle in real time and avoid nearby nerves, vessels, and other sensitive structures.

Ultrasound guidance may improve:

• Treatment accuracy

• Anatomical targeting

• Patient safety

• Distribution of the injected product

• Identification of previously unrecognized pathology

A biologically advanced product will have limited value if it is not delivered to the correct tissue.

What to Expect After a Regenerative Medicine Procedure

Recovery depends on the procedure and tissue treated.

Patients may experience:

• Temporary soreness

• Mild swelling

• Stiffness

• Aching

• Increased sensitivity

• A short-term inflammatory response

• Temporary reduction in exercise tolerance

These effects may be part of the intended healing response.

Most regenerative procedures do not create immediate pain relief. Some patients notice improvement within several weeks, while tendon, ligament, cartilage, and joint remodeling may continue for several months.

A structured recovery plan may include:

1. Initial protection of the treated area

2. Gentle mobility

3. Progressive loading

4. Strength development

5. Sport- or activity-specific rehabilitation

6. Gradual return to unrestricted activity

The timeline should be based on the tissue treated rather than symptoms alone.

Who May Benefit From Regenerative Medicine?

Regenerative medicine may be appropriate for:

• Athletes recovering from sports injuries

• Active adults with chronic tendon or joint pain

• Patients with mild to moderate osteoarthritis

• Individuals attempting to delay joint replacement

• Patients who have not improved with conventional conservative care

• Patients who want to avoid repeated corticosteroid injections

• Patients with partial tendon or ligament injuries

• Individuals seeking a coordinated nonsurgical treatment plan

• Selected patients recovering from orthopedic surgery

Not every patient is a candidate.

Advanced arthritis, severe structural deformity, complete tendon rupture, active infection, uncontrolled medical conditions, certain blood disorders, and other factors may affect treatment eligibility.

Selecting the Right Regenerative Medicine Treatment

The most expensive or aggressive treatment is not automatically the best treatment.

The correct regenerative medicine plan should be based on:

• The specific diagnosis

• Injury severity

• Tissue quality

• Imaging findings

• Duration of symptoms

• Previous treatment

• Patient health

• Functional goals

• Supporting clinical evidence

• Expected recovery demands

For many tendon and joint conditions, a well-prepared PRP treatment may be more appropriate than a cellular product. Other cases may benefit from PRP combined with A2M, plasma-based treatment, BMAC, shockwave therapy, or another procedure.

The treatment should match the biology of the injury.

Regenerative Medicine at Arizona Sports Medicine

At Arizona Sports Medicine, regenerative medicine is not approached as an isolated injection.

Each treatment plan may incorporate:

• Detailed orthopedic examination

• Musculoskeletal ultrasound

• MRI or X-ray review

• Ultrasound-guided procedures

• Platelet-rich plasma

• PRP combined with A2M

• Plasma prolotherapy

• Shockwave therapy

• Tenex treatment

• Physical therapy

• Progressive strengthening

• Peptide and recovery-support protocols

• Nutrition and metabolic optimization

• Long-term injury-prevention planning

The goal is to identify the damaged tissue, select the most appropriate biological treatment, and guide the patient through the complete recovery process.

The Future of Orthopedic Care Is Regenerative

Regenerative medicine is changing how sports injuries, tendon disorders, and degenerative joint conditions are managed.

Rather than relying only on medication, repeated corticosteroid injections, or surgery, physicians and sports medicine providers can now consider treatments that interact directly with the biological healing environment.

PRP already has meaningful clinical support for selected conditions, particularly knee osteoarthritis and lateral epicondylitis. Other orthobiologic treatments, including BMAC, conditioned serum, A2M, and extracellular vesicle technologies, continue to be studied and refined.

These treatments are not universal cures, and they do not eliminate the need for surgery in every patient. Their greatest value comes from appropriate patient selection, accurate diagnosis, precise image-guided treatment, and a carefully structured rehabilitation plan.

The future of orthopedic medicine is not simply replacing damaged tissue.

It is learning how to better support, protect, and restore the tissue the patient already has.

Schedule a Regenerative Medicine Evaluation

Persistent pain does not automatically mean that surgery is the next step.

A comprehensive evaluation can help determine:

• Which structure is causing the pain

• Whether regenerative medicine is appropriate

• Which orthobiologic treatment may provide the greatest benefit

• Whether additional imaging is needed

• Whether PRP, PRP with A2M, plasma prolotherapy, BMAC, or another treatment should be considered

• What rehabilitation plan should accompany the procedure

• What recovery timeline is realistic

Schedule a regenerative medicine consultation with Arizona Sports Medicine to develop a personalized treatment plan based on the diagnosis, goals, and biology of the injury.